Medpace Holdings Inc (MEDP)

NASDAQ
Currency in USD
Disclaimer
246.37
-1.63
(-0.66%)
Closed
246.40
+0.03
(+0.01%)
After Hours
Real-time Data
Day's Range
242.65
248.69
52 wk Range
149.07
282.73
Volume
255,076
Prev. Close
248
Open
247.26
Day's Range
242.65-248.69
52 wk Range
149.07-282.73
Volume
255,076
Average Vol. (3m)
286,891
1-Year Change
66.97%
Shares Outstanding
30,562,773
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
267.00
Upside +8.37%

People Also Watch

37.00
VRT
+2.27%
39.99
STAA
+0.30%
85.67
MHO
+0.71%
73.71
STRL
+0.72%
112.04
ELF
+1.52%
How do you feel today about MEDP?
Vote to see community's results!
or

Medpace Holdings Inc Company Profile

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focuses on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. It also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

Income Statement